OIG Report: FDA Fails to Monitor Adverse Safety Reports_BMJ–FDA Duplicity Exposed
Every federal oversight agency evaluating FDA’s safety performance has given the agency flunking grades. See:https://ahrp.org/cms/content/view/148/55/
TGN1412 Deadly Drug Trial Victims Told To Expect Early Death
The full impact on six healthy volunteers who took part in a catastrophic experiment that nearly killed them is ever so slowly coming to light.
Psychiatrist criminally indicted: Promoting off-label use of drug for depression!
The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
LAT Investigation: NIH Scientist Ties to Pharma
The latest investigative report focusing on financial conflicts of interest by Pulitzer Prize winner, David Willman of the Los Angeles Times, reveals that even as the NIH director, Dr. Elias Zerhouni, announced publicly last year that scientists at the National Institutes of Health would be barred from accepting consulting fees from industry, evidence shows that the ban is clearly not being enforced.
Did regulators fail over SSRIs? BMJ
Dr. David Healy, a formidable critic of the iron grip pharmaceutical corporations wield on the practice of psychiatry as well as on psychiatry’s deficient journal reports, directs his criticism at drug regulators in an article in the current British Medical Journal (BMJ).
Israeli Study: Omega-3 Fatty Acids Help depression in children_Amer J Psychiatry
Reuters reports that a controlled double-blind trial testing Omega-3 Fatty acids in 28 depressed children (aged 6 to 12) found a positive treatment corrolation.
FDA officials conspired with Merck to defame Truth Teller–NEJM credibility ?
Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers.
India’s Outsourced Drug Trials-The Dark Side: BBC
A BBC documentary that airs Thursday, April 27 exposes the disregard for the welfare of patients exploited by US pharmaceutical companies that outsource their clinical drug trials to India, the drug industry’s current favorite drug testing laboratory.
Conflicts of interest: psychiatry’s diagnostic manual DSM-III_DSM-IV
Dr. Robert Spitzer, who has continued to play a central role in DSM revisions since 1980, claim he does not think a conflict of interest exists.
See list of APA Task Force on DSM-IV and DSM-IV Revised Text at: https://ahrp.org/cms/content/view/145/27/
Company Knew of the Catastrophic Risk–so did the British Medicines Authority
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
British Rethinking Rules After Ill-Fated Drug Trial_NYT
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
London Drug Trial Catastrophe: Collapse of Science and Ethics
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.